FDA Finalizes on Controlled Correspondence

FDA Finalizes on Controlled Correspondence

The US Food and Drug Administration (FDA) has finalized its guidance to generic drug manufacturers on how to seek drug development information through the controlled correspondence process. The guidance incorporates changes that were part of the reauthorization of the...
FDA Fires Warning on Sex and Weight Products

FDA Fires Warning on Sex and Weight Products

The FDA fired fresh consumer warning on tainted male sex enhancement and weight-loss products sold on Amazon and eBay showcases FDA’s ongoing frustrations with undeclared ingredients, including pharmaceuticals. Despite a long list of warnings over the years about...
Supreme Court Settles Fate of DMAA

Supreme Court Settles Fate of DMAA

The U.S. Supreme Court has settled its fate and denied a petition for a writ of certiorari filed by a supplement manufacturer Hi-Tech Pharmaceuticals and its owner, Jared Wheat. The nation’s highest court has rejected a request to review a case involving the legality...